Toenail arsenic content and cutaneous melanoma in Iowa

American Journal of Epidemiology

Volumn 160, Issue 7, 2004, Pages 679-687

  Freeman, Laura E Beane ^a,b   Dennis, Leslie K ^b   Lynch, Charles F ^b   Thorne, Peter S ^b   Just, Craig L ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c IA United States   (United States)

Author keywords

Arsenic; Case control studies; Melanoma; Skin neoplasms

Indexed keywords

ARSENIC; DRINKING WATER; GRAPHITE;

ARSENIC; BIOACCUMULATION; CANCER; RISK FACTOR;

ADULT; AGED; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; MELANOMA; NAIL; SKIN CANCER; SURVIVAL RATE; TOXIN ANALYSIS; UNITED STATES; WATER CONTAMINATION;

ADULT; AGED; AGED, 80 AND OVER; ARSENIC; CASE-CONTROL STUDIES; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; IOWA; MALE; MELANOMA; MIDDLE AGED; NAILS; RISK FACTORS; SKIN NEOPLASMS;

IOWA; NORTH AMERICA; UNITED STATES;

EID: 4644242674     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwh267     Document Type: Article

References (41)

1. Ries LAG, Eisner MP, Kosary CL, et al. SEER cancer statistics review, 1975-2000. Bethesda, MD: National Cancer Institute, 2003. (http:/seer.cancer. gov/csr/1975_2000).
2. Morton WE, Dunnette DA. Health effects of environmental arsenic. In: Nriagu JO, ed. Arsenic in the environment. Part II: human health and ecosystem effects. New York, NY: John Wiley & Sons, 1994.
3. Hsueh YM, Cheng GS, Wu MM, et al. Multiple risk factors associated with arsenic-induced skin cancer: effects of chronic liver disease and malnutritional status. Br J Cancer 1995;71:109-14.
4. Agency for Toxic Substances and Disease Registry. Toxicological profile for arsenic. Atlanta, GA: Agency for Toxic Substances and Disease Registry, US Department of Health and Human Services, 2000. (Publication CAS#7440-38-2).
5. Gebel T. Confounding variables in the environmental toxicology of arsenic. Toxicology 2000;144:155-62.
6. VanDorpe P. Arsenic in Iowa's municipal water supplies. Iowa Groundwater Q 2000;11:13-19.
7. Ryker SJ. Mapping arsenic in groundwater. Geotimes 2001;46:34-6.
8. Chen CJ, Chuang YC, Lin TM, et al. Malignant neoplasms among residents of a Blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res 1985;45:5895-9.
9. Karagas MR, Stukel TA, Morris JS, et al. Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study. Am J Epidemiol 2001;153:559-65.
10. Tseng WP, Chu HM, How SW, et al. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J Natl Cancer Inst 1968;40:453-63.
11. Pesch B, Ranft U, Jakubis P, et al. Environmental arsenic exposure from a coal-burning power plant as a potential risk factor for nonmelanoma skin carcinoma: results from a case-control study in the district of Prievidza, Slovakia. Am J Epidemiol 2002;155:798-809.
12. Woodhead AD, Setlow RB, Tanaka M. Environmental factors in nonmelanoma and melanoma. J Epidemiol 1999;9(6S): S102-14.
13. Smith AH, Hopenhayn-Rich C, Bates MN, et al. Cancer risks from arsenic in drinking water. Environ Health Perspect 1992;97:259-67.
14. Lewis DR, Southwick JW, Oullet-Hellstrom R, et al. Drinking water arsenic in Utah: a cohort mortality study. Environ Health Perspect 1999;107:359-65.
15. Watanabe C, Inaoka T, Kadono T, et al. Males in rural Bangladeshi communities are more susceptible to chronic arsenic poisoning than females: analyses based on urinary arsenic. Environ Health Perspect 2001;109:1265-70.
16. Schroeder H, Balassa JJ. Abnormal trace metals in man: arsenic. J Chronic Dis 1966;19:85-106.
17. Henke G, Nucci A, Quieroz L. Detection of repeated arsenical poisoning by neutron activation analysis of foot nail segments. Arch Toxicol 1982;50:125-31.
18. Hornung RW, Reed LD. Estimation of average concentration in the presence of nondetectable values. Appl Occup Environ Hyg 1990;5:46-51.
19. Hosmer DW, Lemeshow S. Applied logistic regression. New York, NY: John Wiley & Sons, 1989.
20. Urist M, Miller D, Maddox W. Malignant melanoma. In: Murphy G, Lawrence W, Lenhard R, eds. American Cancer Society textbook in clinical oncology. Atlanta, GA: American Cancer Society, 1995.
21. McCarthy WH, Shaw HM. The surgical treatment of primary melanoma. Hematol Oncol Clin North Am 1998;12:797-805.
22. Wagner JD, Gordon MS, Chuang TY, et al. Current therapy of cutaneous melanoma. Plast Reconstr Surg 2000;105:1774-99.
23. Pavlick AC. Chemotherapy approaches to melanoma. Dermatol Clin 2002;20:709-12.
24. Sun W, Schuchter LM. Metastatic melanoma. Curr Treat Options Oncol 2001;2:193-202.
25. Karagas MR, Tosteson TD, Blum J, et al. Measurement of low levels of arsenic exposure: a comparison of water and toenail concentrations. Am J Epidemiol 2000;152:84-90.
26. Garland M, Morris JS, Rosner BA, et al. Toenail trace element levels as biomarkers: reproducibility over a 6-year period. Cancer Epidemiol Biomarkers Prev 1993;2:493-7.
27. Holly EA, Kelly JW, Shpall SN, et al. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 1987;17:459-68.
28. Beitner H, Norell SE, Ringborg U, et al. Malignant melanoma: aetiological importance of individual pigmentation and sun exposure. Br J Dermatol 1990;122:43-51.
29. Beral V, Evans S, Shaw H, et al. Cutaneous factors related to the risk of malignant melanoma. Br J Dermatol 1983;109:165-72.
30. Holman CDJ, Armstrong BK. Pigmentary traits, ethnic origin, benign nevi and family history as risk factors for cutaneous malignant melanoma. J Natl Cancer Inst 1984;72:257-66.
31. Elwood JM, Gallagher RP, Hill GB, et al. Cutaneous melanoma in relation to intermittent and constant sun exposure: the Western Canada melanoma study. Int J Cancer 1985;35:427-33.
32. Dubin N, Moseson M, Pasternack BS. Epidemiology of malignant melanoma: pigmentary traits, ultraviolet radiation, and the identification of high risk populations. Recent Results Cancer Res 1986;102:56-75.
33. Lynch CF, Logsden-Sackett N, Edwards SL, et al. The driver's license list as a population-based sampling frame in Iowa. Am J Public Health 1994;84:469-72.
34. Adimora AA, Schoenbach VJ, Martinson FE, et al. Driver's license and voter registration lists as population-based sampling frames for rural African Americans. Ann Epidemiol 2001;11:385-8.
35. Luchtrath H. The consequences of chronic arsenic poisoning among Moselle wine growers: pathoanatomical investigations of post-mortem examinations performed between 1960 and 1977. J Cancer Res Clin Oncol 1983;50:173-82.
36. Chen CJ, Wang CJ. Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant melanoma. Cancer Res 1990;50:5470-4.
37. Cuzick J, Evans S, Gillman M, et al. Medicinal arsenic and internal malignancies. Br J Cancer 1982;45:904-11.
38. Tsuda T, Babazono A, Yamamoto E, et al. Ingested arsenic and internal cancer: a historical cohort study followed for 33 years. Am J Epidemiol 1995;141:198-209.
39. Wu MM, Kuo TL, Hwang YH, et al. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol 1989;130:1123-32.
40. Cantor KP, Shy CM, Chilvers C. Water pollution. In: Schottenfeld D, Fraumeni JF, eds. Cancer epidemiology and prevention. New York, NY: Oxford University Press, 1996.
41. State of Iowa Public Drinking Water Program. 2001 annual compliance report. Des Moines, IA: Iowa Department of Natural Resources-Environmental Protection Division, Water Quality Bureau, Drinking Water Supply Section, 2002. (http:// www.state.ia.us/government/dnr/organiza/epd/wtrsuply/report/ 01/01final.pdf).